Pharma News

Amgen to invest $600m in new US science and innovation hub

Recall Alert: Popular Supplement for Men Swapped for Erectile Dysfunction Drug

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.

CapVest to buy control of generics giant Stada in €10bn deal

Clopidogrel might be better than aspirin for long-term heart disease

SFDA approves rapid biotech test for early Alzheimer’s detection

'Young' immune cells reverse signs of neurodegenerative brain changes in preclinical study by Cedars-Sinai Medical Center

Santhera and Ikris sign distribution agreement for DMD drug in India

With FDA nod, Sanofi's Wayrilz becomes 1st US BTK drug approved for immune thrombocytopenia

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy and Zepbound

D3S-001 Receives FDA Breakthrough Therapy, Orphan Drug Designations in Select KRAS G12C-Mutant Solid Tumors

FDA approves mRNA vaccines for new Covid-19 season amid political tension